Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD16 IgG with similar domains from an anti-HER2 antibody via short peptide linkers, or vice versa. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fv-IgG) (BSDG-038). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS